Xiaoxi Zhuang
Guangzhou Institutes of Biomedicine and Health(CN)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways, Quinazolinone synthesis and applications, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Self-Assembled Peptide Nanofibers Designed as Biological Enzymes for Catalyzing Ester Hydrolysis(2014)227 cited
- → A Photosensitizer-Loaded DNA Origami Nanosystem for Photodynamic Therapy(2016)180 cited
- → Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib(2013)175 cited
- → 1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as Orally Bioavailable Transcriptional Function Suppressors of Estrogen-Related Receptor α(2013)69 cited
- → Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer(2021)47 cited
- → New benzimidazole-2-urea derivates as tubulin inhibitors(2014)45 cited
- → Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor β Agonist(2022)44 cited
- → N-(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf Inhibitors(2015)37 cited
- → New thiazole carboxamides as potent inhibitors of Akt kinases(2011)34 cited
- → Structure-Based Discovery and Optimization of Furo[3,2-c]pyridin-4(5H)-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors(2022)27 cited